These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16098242)

  • 1. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
    Mao JT; Cui X; Reckamp K; Liu M; Krysan K; Dalwadi H; Sharma S; Hazra S; Strieter R; Gardner B; Dubinett SM
    Clin Lung Cancer; 2005 Jul; 7(1):30-9. PubMed ID: 16098242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
    Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
    Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS; Surh YJ
    Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted roles of cyclooxygenase-2 in lung cancer.
    Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
    Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis.
    Pace E; Siena L; Ferraro M; Profita M; Mondello P; Chiappara G; Montalbano AM; Giarratano A; Bonsignore G; Gjomarkaj M
    Eur J Cancer; 2006 Sep; 42(14):2382-9. PubMed ID: 16899364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
    Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
    Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA; Zhou Y; Morita S; Der CJ
    Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
    Liao Z; Milas L
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
    Peebles KA; Lee JM; Mao JT; Hazra S; Reckamp KL; Krysan K; Dohadwala M; Heinrich EL; Walser TC; Cui X; Baratelli FE; Garon E; Sharma S; Dubinett SM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1405-21. PubMed ID: 17944566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
    Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
    Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
    Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
    Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
    Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
    Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.